Research shows that IGF-1 promotes the anagen (growth) phase and inhibits the catagen (regression) transition
Semaglutide and Tirzepatide cannot be prescribed to anyone with the following conditions and should not be purchased: BMI under 26, Gastroparesis (paralysis of your intestines), Triglycerides over 600 at any point, Pancreatic cancer, Pancreatitis, Type 1 diabetes, Hypoglycemia (low blood sugar), Insulin-dependent diabetes, Thyroid cancer, Family history of thyroid cancer, Personal or family history of Multiple Endocrine Neoplasia (MEN-2) syndrome, Anorexia or bulimia, Current symptomatic gallstones, Drug or alcohol abuse, Recent bariatric surgery, Diabetic retinopathy, current pregnancy or breastfeeding, plans to become pregnant, or history of allergic reaction to Semaglutide or Tirzepatide
Orders are typically fulfilled the same or following business day
Secondary hyperhidrosis: This type is secondary to medical conditions such as diabetes, menopause, infections, or certain medications
How Semaglutide Affects Insulin and Blood Sugar Levels One of Semaglutides primary functions is improving insulin regulation